MiR-520e is capable of directly binding to the 3’UTR of cyclinD1 mRNA to promote the degradation of cyclinD1 mRNA, leading to the inhibition of cyclinD1 in breast cancer. The gene discussed is CCND1; the disease is breast carcinoma.